Journalartikel

Cell cycle regulatory molecular profiles of pediatric T-cell lymphoblastic leukemia and lymphoma


AutorenlisteBonn, Bettina R.; Krieger, David; Burkhardt, Birgit

Jahr der Veröffentlichung2012

Seiten557-568

ZeitschriftLeukemia & Lymphoma

Bandnummer53

Heftnummer4

ISSN1042-8194

eISSN1029-2403

DOI Linkhttps://doi.org/10.3109/10428194.2011.616614

VerlagTaylor and Francis Group


Abstract
Proper regulation of the cell cycle plays a fundamental role in any organism, as it impacts cellular division, differentiation and death. In this intricate process, progression through the phases of the cell cycle relies on various cyclin-cyclin-dependent kinase protein complexes that are regulated by multiple cyclin-dependent kinase inhibitors. Ultimately, the transcription factor E2F is influenced by this cascade and regulates the mRNA levels of proteins needed for cell cycle progression. Thus, disturbance of cell cycle regulation has been shown to be responsible for various types of cancer including adult and pediatric T-cell acute lymphoblastic leukemia and lymphoma (T-ALL and T-LBL, respectively), which are suggested to arise due to developmental arrest of precursor T lymphoblasts at certain early time points in T-cell maturation. Therapy optimization in recent years has resulted in good prognoses for patients of both malignancies. Here, we provide an overview of current knowledge of the cell cycle and its regulators with respect to pediatric T-ALL and T-LBL, both on molecular events underlying the disturbance of cell cycle regulation and on clinical parameters of affected children.



Zitierstile

Harvard-ZitierstilBonn, B., Krieger, D. and Burkhardt, B. (2012) Cell cycle regulatory molecular profiles of pediatric T-cell lymphoblastic leukemia and lymphoma, Leukemia & Lymphoma, 53(4), pp. 557-568. https://doi.org/10.3109/10428194.2011.616614

APA-ZitierstilBonn, B., Krieger, D., & Burkhardt, B. (2012). Cell cycle regulatory molecular profiles of pediatric T-cell lymphoblastic leukemia and lymphoma. Leukemia & Lymphoma. 53(4), 557-568. https://doi.org/10.3109/10428194.2011.616614



Schlagwörter


ABERRANT DNA METHYLATIONACUTE LYMPHOCYTIC-LEUKEMIAATAXIA-TELANGIECTASIAATM-DEFICIENT MICECLINICAL-SIGNIFICANCEDEPENDENT KINASE INHIBITORSFRANKFURT-MUNSTER GROUPHOMOZYGOUS DELETIONSp53 genepediatric T-cell lymphoblastic leukemiapediatric T-cell lymphoblastic lymphomaTUMOR-SUPPRESSOR GENES


Nachhaltigkeitsbezüge


Zuletzt aktualisiert 2025-21-05 um 18:40